Navigation thread
Translational research in hepatic oncology
Featured publications
-
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Llovet, JM; Willoughby, CE; Singal, AG; Greten, TF; Heikenwälder, M;El-Serag, HB; Finn, RS; Friedman, SL.Reference:Nature Reviews Gastroenterology & Hepatology 2023.
-
International Liver cancer Association (ILCA) White Paper on Hepatocellular carcinoma Risk Stratification and Surveillance
Singal, Amit G; Sanduzzi-Zamparelli, Marco; Nahon, Pierre; Ronot, Maxime; Hoshida, Yujin;(...)Vilgrain, Valerie; Marrero, Jorge; Llovet, Josep M; Parikh, Neehar D; Villanueva, Augusto.Reference:Journal Of Hepatology 2023.
-
Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma
Haber PK; Castet F; Torres-Martin M; Andreu-Oller C; Puigvehí M;(...)Finn RS; Thung S; Villanueva A; Sia D; Llovet JM.Reference:Gastroenterology 2023.
-
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification
Montironi, Carla; Castet, Florian; Haber, Philipp K; Pinyol, Roser; Torres-Martin, Miguel;(...)Villanueva, Augusto; Friedman, Scott L; Uzilov, Andrew; Sia, Daniela; Llovet, Josep M.Reference:Gut 2023.
-
Immunotherapies for hepatocellular carcinoma
Llovet JM; Castet F; Heikenwalder M; Maini MK; Mazzaferro V;Pinato DJ; Pikarsky E; Zhu AX; Finn RS.Reference:Nature Reviews Clinical Oncology 2021.
-
Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Pinyol, R; Torrecilla, S; Wang, H; Montironi, C; Piqué-Gili, M;(...)Heikenwalder, M; Sanyal, A; Friedman, SL; Sia, D; Llovet, JM.Reference:Journal Of Hepatology 2021.
-
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Pfister, D; Núñez, NG; Pinyol, R; Govaere, O; Pinter, M;(...)Amit, I; Knolle, P; Becher, B; Llovet, JM; Heikenwalder, M.Reference:Nature 2021.
-
Hepatocellular carcinoma
Llovet, Josep M; Kelley, Robin Kate; Villanueva, Augusto; Singal, Amit G; Pikarsky, Eli;Roayaie, Sasan; Lencioni, Riccardo; Koike, Kazuhiko; Zucman-Rossi, Jessica; Finn, Richard S.Reference:Nature Reviews Disease Primers 2021.
-
Sorafenib in Advanced Hepatocellular Carcinoma
Llovet, JM; Ricci, S; Mazzaferro, V; Hilgard, P; Gane, E;(...)Giannaris, T; Shan, M; Moscovici, M; Voliotis, D; Bruix, J.Reference:New England Journal Of Medicine 2008.
-
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Hoshida, Yujin; Villanueva, Augusto; Kobayashi, Masahiro; Peix, Judit; Chiang, Derek Y;(...)Bruix, Jordi; Friedman, Scott L; Kumada, Hiromitsu; Llovet, Josep M; Golub, Todd R.Reference:New England Journal Of Medicine 2008.